India needs to diversify pharma raw material imports, up R&D spends: RBI paper

"The high import dependency and surprisingly low R&D intensity of exports in the Indian pharmaceutical sector call for timely diversification of source countries for importing raw materials so as to mitigate potential supply-side bottlenecks," the paper by Shibanjan Dutta and Dhirendra Gajbhiye said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3epcqyt
via IFTTT